B-cell malignancies in microRNA Eμ-miR-17∼92 transgenic mice
Open Access
- 21 October 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (45), 18208-18213
- https://doi.org/10.1073/pnas.1315365110
Abstract
miR-17∼92 is a polycistronic microRNA (miR) cluster (consisting of miR-17, miR-18a, miR-19a, miR-19b, miR-20a, and miR-92a) which frequently is overexpressed in several solid and lymphoid malignancies. Loss- and gain-of-function studies have revealed the role of miR-17∼92 in heart, lung, and B-cell development and in Myc-induced B-cell lymphomas, respectively. Recent studies indicate that overexpression of this locus leads to lymphoproliferation, but no experimental proof that dysregulation of this cluster causes B-cell lymphomas or leukemias is available. To determine whether miR-17∼92- overexpression induces lymphomagenesis/leukemogenesis, we generated a B-cell–specific transgenic mouse model with targeted overexpression of this cluster in B cells. The miR-17∼92 overexpression was driven by the Eµ-enhancer and Ig heavy-chain promoter, and a 3′ GFP tag was added to the transgene to track the miR expression. Expression analysis using Northern Blot and quantitative RT-PCR confirmed 2.5- to 25-fold overexpression of all six miRs in the transgenic mice spleens as compared with spleens from wild-type mice. Eµ-miR-17∼92 mice developed B-cell malignancy by the age of 12–18 mo with a penetrance of ∼80% (49% splenic B-cell lymphoproliferative disease, 28% lymphoma). At this stage mice exhibited severe splenomegaly with abnormal B-cell–derived white pulp expansion and enlarged lymph nodes. Interestingly, we found three classes of B-cell lymphomas/leukemias at varying grades of differentiation. These included expansion of CD19+ and CD5+ double-positive B cells similar to the aggressive form of human B-cell chronic lymphocytic leukemia, B220+ CD43+ B1-cell proliferation, and a CD19+ aggressive diffuse large B-cell lymphoma–like disease, as assessed by flow cytometry and histopathological analysis.Keywords
This publication has 19 references indexed in Scilit:
- microRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphomaBlood, 2013
- Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomasGenes & Development, 2009
- Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytesNature Immunology, 2008
- Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA ClustersCell, 2008
- Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92Oncogene, 2007
- Animal models for chronic lymphocytic leukemiaJournal of Cellular Biochemistry, 2006
- A Polycistronic MicroRNA Cluster, miR-17-92, Is Overexpressed in Human Lung Cancers and Enhances Cell ProliferationCancer Research, 2005
- A microRNA polycistron as a potential human oncogeneNature, 2005
- Molecular Evolution of a MicroRNA ClusterJournal of Molecular Biology, 2004
- Human chronic lymphocytic leukemia modeled in mouse by targetedTCL1expressionProceedings of the National Academy of Sciences of the United States of America, 2002